Abstract:Objective Cardiac surgery is indicated in up to 50% of all patients diagnosed with infective endocarditis, and perioperative morbidity and mortality remain high. Allogeneic blood transfusion is very common in cardiac surgery, and is strongly associated with adverse outcomes. Data on transfusion rates, specifically in patients with infective endocarditis, is scare. Aim of the present study was to determine contemporary transfusion and coagulation management practice, as well as short and long-term mortality, including sex differences, in adult patients with infective endocarditis undergoing cardiac surgery. Design and method Retrospective multicentre cohort study. Data from all 15 cardiac surgery centres were obtained from the national quality physician-driven, patient-focused Netherlands Heart Registration (NHR). In the quality policies set by the Dutch Society for Cardiology and Dutch Association for Thoracic Surgery, predetermined variables are documented, then submitted to the NHR by participating centres. Data can be requested for research purposes.In this preliminary analysis, all adult patients with infective endocarditis who underwent cardiac surgery between 1 January 2016 and 31 December 2021 were included. Descriptive statistics were used to describe incidences. A logistic regression was performed to evaluate the effect of confounders. Results and conclusions Preliminary Results: A total of 2280 patients were included, of which 1738 (76%) were males, and the mean age was 61.8 (±13.3) years. The urgency of surgery was elective in 13%, urgent in 71%, emergency in 15% and salvage in 1% of patients. The mean preoperative haemoglobin level was 6.7 (± 1.1) mmol/L and significantly higher in males (6.8 ± 1.1 versus 6.5 ± 1.0, p<.001). Preoperative anaemia, defined by World Health Organisation criteria, was present in 89% of patients, with no significant difference between the sexes.(Table1)Transfusion of allogeneic blood products was very common, with 77% receiving at least one unit of intraoperative red blood cell (RBC) transfusion. The percentage of females receiving RBC (88%) was significantly higher than in males (74%; p<.001). Overall, 29% and 43% of patients received at least one unit of intraoperative plasma or platelet transfusion, respectively – with no differences between the sexes. Surgical re-intervention due to bleeding or tamponade within 30 days after surgery was documented in 11% of patients.(Table2)Mortality within 30 days was 11%, with a statistically significant difference between males (10%) and females (14%, p=.006). At one year, mortality was 17% (males,(16%) and females (20%)). Mortality was significantly higher in females (p=.028). Adjusted logistic regression showed that intraoperative RBC transfusion were significantly associated with mortality within 30 days. The adjusted odds ratio was 4.370 [2.396-7.973], p<.001.(Table 3) Conclusion The incidence of preoperative anaemia is very high in patients with infective endocarditis undergoing cardiac surgery. Likewise, the percentage of patients receiving RBC transfusion is high, especially in females. In turn, RBC transfusion is associated with increased mortality. Overall mortality remains high, with females at increased risk for short-term mortality. Further research to unravel endocarditis-related coagulopathy and optimise perioperative transfusion and coagulation management appears crucial to improve outcomes in these high risk surgeries.

Intraoperative Hemoadsorption in Patients With Native Mitral Valve Infective Endocarditis

Intraoperative autologous based blood conservation strategies in mitral valve replacement

Blood Conservation Strategies in Cardiac Valve Replacement

Blood conservation strategies in cardiac valve replacement: A retrospective analysis of 1645 patients.

Haemoadsorption in infective endocarditis: a systematic review

Whole Blood Adsorber During CPB and Need for Vasoactive Treatment After Valve Surgery in Acute Endocarditis: A Randomized Controlled Study

Outcome of patient undergoing redo mitral valve surgery with incidence rate of mitral valve infective endocarditis

Surgical treatment of valve endocarditis in high-risk patients and predictors of long-term outcomes

Contraindicated or Safely Possible?

Intractable Mechanical Hemolytic Anemia Complicating Mitral Valve Surgery: a Case Series Study

Surgical Interventions for Complex Native Valve Endocarditis

Anaemia, Transfusion Practice And Mortality In Patients With Infective Endocarditis Undergoing Cardiac Surgery– A Nationwide Study In The Netherlands

Outcomes following heart valve surgery in patients with infective endocarditis and preoperative septic cerebral embolism: insights from the CAMPAIGN study group

Improved outcome for seriously ill open heart surgery patients: focus on reoperation and endocarditis

Surgical procedure versus medical treatment for infective endocarditis associated to mortality in Mexican population

Modifiable risk factors of immediate and long-term outcomes in the operable and inoperable with left-sided infective endocarditis

Mitral valve repair and replacement in infectious endocarditis: a systematic review and meta-analysis of clinical outcome

Key Points in the Surgical Treatment of Infective Endocarditis : a Report of 106 Cases

Clinical Analysis of 161 Cases of Surgical Treatment of Infective Endocarditis.

The Surgical Treatment of Infective Endocarditis: A Comprehensive Review

Intraoperative Fluid Balance and Perioperative Outcomes After Aortic Valve Surgery